{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T08:43:18Z","timestamp":1794300198269,"version":"4.9.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF OC0013659"],"award-info":[{"award-number":["NNF OC0013659"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["316664"],"award-info":[{"award-number":["316664"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004212","name":"P\u00e4ivikki ja Sakari Sohlbergin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015736","name":"Folkh\u00e4lsan Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"Helsingin ja Uudenmaan Sairaanhoitopiiri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004325","name":"Signe and Ane Gyllenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.diabres.2023.110620","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T19:31:39Z","timestamp":1678563099000},"page":"110620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The relationship between FGF23 and body composition according to albuminuria stage in type 1 diabetes"],"prefix":"10.1016","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8101-912X","authenticated-orcid":false,"given":"Erika B.","family":"Parente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5200-4597","authenticated-orcid":false,"given":"Aila J.","family":"Ahola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5626-4190","authenticated-orcid":false,"given":"Anmol","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8414-7285","authenticated-orcid":false,"given":"Markku","family":"Lehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Henrik","family":"Groop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.diabres.2023.110620_b0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00002.2011","article-title":"Regulation and function of the FGF23\/klotho endocrine pathways","volume":"92","author":"Martin","year":"2012","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.diabres.2023.110620_b0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/toxins11030175","article-title":"FGF23, biomarker or target?","volume":"11","author":"Rodelo-Haad","year":"2019","journal-title":"Toxins"},{"issue":"2","key":"10.1016\/j.diabres.2023.110620_b0015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","article-title":"Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population","volume":"207","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.diabres.2023.110620_b0020","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jbmr.275","article-title":"Anti-FGF-23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement of Hyp mice","volume":"26","author":"Aono","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.diabres.2023.110620_b0025","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/jac\/dkv027","article-title":"Circulating fibroblast growth factor 23 (FGF23) levels are associated with metabolic disturbances and fat distribution but not cardiovascular risk in HIV-infected patients","volume":"70","author":"Domingo","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diabres.2023.110620_b0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/ATVBAHA.110.214619","article-title":"Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals","volume":"31","author":"Mirza","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.diabres.2023.110620_b0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.clnu.2016.12.010","article-title":"Associations of serum fibroblast growth factor 23 levels with obesity and visceral fat accumulation","volume":"37","author":"Hu","year":"2018","journal-title":"Clin Nutr"},{"issue":"12","key":"10.1016\/j.diabres.2023.110620_b0040","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.2337\/db15-0254","article-title":"Genetic evidence for a causal role of obesity in diabetic kidney disease","volume":"64","author":"Todd","year":"2015","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.diabres.2023.110620_b0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000368498","article-title":"Association of visceral fat area with chronic kidney disease and metabolic syndrome risk in the general population: Analysis using multi-frequency bioimpedance","volume":"40","author":"Kang","year":"2015","journal-title":"Kidney Blood Press Res"},{"issue":"5","key":"10.1016\/j.diabres.2023.110620_b0050","doi-asserted-by":"crossref","first-page":"e0153588","DOI":"10.1371\/journal.pone.0153588","article-title":"Abdominal obesity, race and chronic kidney disease in young adults: Results from NHANES 1999\u20132010","volume":"11","author":"Sarathy","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.diabres.2023.110620_b0055","first-page":"585","article-title":"Abdominal fat distribution and coronary heart disease risk factors in men-waist\/height ratio as a simple and useful predictor","volume":"19","author":"Hsieh","year":"1995","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"2","key":"10.1016\/j.diabres.2023.110620_b0060","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/JOE-15-0533","article-title":"Insulin resistance and sarcopenia: mechanistic links between common co-morbidities","volume":"229","author":"Cleasby","year":"2016","journal-title":"J Endocrinol"},{"issue":"5","key":"10.1016\/j.diabres.2023.110620_b0065","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/jcm8050712","article-title":"Prognostic impact of low skeletal muscle mass on major adverse cardiovascular events in coronary artery disease: A propensity score-matched analysis of a single center all-comer cohort","volume":"8","author":"Kang","year":"2019","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.diabres.2023.110620_b0070","doi-asserted-by":"crossref","first-page":"F1087","DOI":"10.1152\/ajprenal.00340.2016","article-title":"Insulin resistance in chronic kidney disease: a systematic review","volume":"311","author":"Spoto","year":"2016","journal-title":"Am J Physiol-Ren Physiol"},{"issue":"3","key":"10.1016\/j.diabres.2023.110620_b0075","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2012.03.040","article-title":"Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study)","volume":"60","author":"Ix","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.diabres.2023.110620_b0080","doi-asserted-by":"crossref","first-page":"e003486","DOI":"10.1161\/JAHA.116.003486","article-title":"Plasma fibroblast growth factor 23: Clinical correlates and association with cardiovascular disease and mortality in the Framingham Heart Study","volume":"5","author":"Haring","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.diabres.2023.110620_b0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000440984","article-title":"Elevated fibroblast growth factor 23 concentration: prediction of mortality among chronic kidney disease patients","volume":"6","author":"Chathoth","year":"2015","journal-title":"Cardiorenal Med"},{"issue":"7","key":"10.1016\/j.diabres.2023.110620_b0090","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3109\/07853890.2010.503660","article-title":"Depression is associated with the metabolic syndrome among patients with type 1 diabetes","volume":"42","author":"Ahola","year":"2010","journal-title":"Ann Med"},{"issue":"7","key":"10.1016\/j.diabres.2023.110620_b0095","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/1403494812460346","article-title":"Sense of coherence, food selection and leisure time physical activity in type 1 diabetes","volume":"40","author":"Ahola","year":"2012","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.diabres.2023.110620_b0100","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.diabres.2023.110620_b0105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/oby.22108","article-title":"Precision of DXA-derived visceral fat measurements in a large sample of adults of varying body size","volume":"26","author":"Meredith-Jones","year":"2018","journal-title":"Obesity"},{"issue":"5","key":"10.1016\/j.diabres.2023.110620_b0110","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/dc11-2235","article-title":"Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease","volume":"35","author":"Wahl","year":"2012","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2023.110620_b0115","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.2337\/dc13-2235","article-title":"FGF23 in type 2 diabetic patients: relationship with bone metabolism and vascular disease","volume":"37","author":"Reyes-Garcia","year":"2014","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2023.110620_b0120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jdiacomp.2013.09.004","article-title":"Insulin resistance is associated with fibroblast growth factor-23 in stage 3\u20135 chronic kidney disease patients","volume":"28","author":"Garland","year":"2014","journal-title":"J Diabetes Complications"},{"issue":"3","key":"10.1016\/j.diabres.2023.110620_b0125","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ecl.2008.07.002","article-title":"The adipocyte as an endocrine cell","volume":"37","author":"Halberg","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"10.1016\/j.diabres.2023.110620_b0130","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/eje.0.1490129","article-title":"Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level","volume":"149","author":"Winkler","year":"2003","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.diabres.2023.110620_b0135","first-page":"178","article-title":"Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients","volume":"26","author":"Bertin","year":"2000","journal-title":"Diabetes Metab"},{"issue":"4","key":"10.1016\/j.diabres.2023.110620_b0140","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/MNH.0000000000000232","article-title":"Inflammation regulates FGF23 production","volume":"25","author":"Francis","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.diabres.2023.110620_b0145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.mce.2014.10.007","article-title":"Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli","volume":"399","author":"Ito","year":"2015","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.diabres.2023.110620_b0150","doi-asserted-by":"crossref","first-page":"e0122885","DOI":"10.1371\/journal.pone.0122885","article-title":"Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adults","volume":"10","author":"Hanks","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.diabres.2023.110620_b0155","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1210\/en.2011-1878","article-title":"Long-term Fgf23 deficiency does not influence aging, glucose homeostasis, or fat metabolism in mice with a nonfunctioning vitamin D receptor","volume":"153","author":"Streicher","year":"2012","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.diabres.2023.110620_b0160","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.diabres.2023.110620_b0165","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/ndt\/gfx344","article-title":"Circulating adiponectin modifies the FGF23 response to vitamin D receptor activation: a post hoc analysis of a double-blind, randomized clinical trial","volume":"33","author":"Spoto","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diabres.2023.110620_b0170","doi-asserted-by":"crossref","first-page":"18575","DOI":"10.1038\/s41598-020-75667-5","article-title":"Waist-height ratio and waist are the best estimators of visceral fat in type 1 diabetes","volume":"10","author":"Parente","year":"2020","journal-title":"Sci Rep"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723000955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723000955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:52:39Z","timestamp":1777510359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822723000955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":34,"alternative-id":["S0168822723000955"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110620","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between FGF23 and body composition according to albuminuria stage in type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110620"}}